您的购物车当前为空
Demethoxyfumitremorgin C and tryprostatin B are fungal inhibitors of mammalian cell cycle progression at the G(2)/M transition. Demethoxyfumitremorgin C inhibits the proliferation of PC3 human prostate cancer cells via the intrinsic (mitochondrial) and extrinsic pathway, followed by downstream events leading to apoptotic cell death, it could therefore, serve as a useful agent to treat human advanced prostate cancer.

Demethoxyfumitremorgin C and tryprostatin B are fungal inhibitors of mammalian cell cycle progression at the G(2)/M transition. Demethoxyfumitremorgin C inhibits the proliferation of PC3 human prostate cancer cells via the intrinsic (mitochondrial) and extrinsic pathway, followed by downstream events leading to apoptotic cell death, it could therefore, serve as a useful agent to treat human advanced prostate cancer.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5 mg | ¥ 5,700 | 待询 |
| 产品描述 | Demethoxyfumitremorgin C and tryprostatin B are fungal inhibitors of mammalian cell cycle progression at the G(2)/M transition. Demethoxyfumitremorgin C inhibits the proliferation of PC3 human prostate cancer cells via the intrinsic (mitochondrial) and extrinsic pathway, followed by downstream events leading to apoptotic cell death, it could therefore, serve as a useful agent to treat human advanced prostate cancer. |
| 分子量 | 349.434 |
| 分子式 | C21H23N3O2 |
| CAS No. | 111768-16-2 |
| Smiles | [H][C@@]12CCCN1C(=O)[C@]1([H])Cc3c([nH]c4ccccc34)[C@H](C=C(C)C)N1C2=O |wU:1.0,8.9,wD:20.23,(-6.13,-6.74,;-5.74,-5.25,;-7.26,-5.51,;-7.97,-4.14,;-6.89,-3.04,;-5.51,-3.73,;-4.08,-3.17,;-3.85,-1.64,;-2.87,-4.13,;-2.64,-2.6,;-1.44,-3.56,;-.23,-4.52,;-.46,-6.04,;.91,-6.73,;1.99,-5.63,;3.53,-5.7,;4.36,-4.4,;3.65,-3.04,;2.11,-2.97,;1.28,-4.27,;-1.9,-6.61,;-2.12,-8.13,;-.92,-9.09,;-1.15,-10.61,;.51,-8.53,;-3.1,-5.65,;-4.53,-6.21,;-4.76,-7.74,)| |
| 密度 | 1.33 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
对于不同动物的给药剂量换算,您也可以参考 更多